Guidance

Advanced pain discovery platform: frequently asked questions

A list of anticipated questions about the advanced pain discovery platform opportunity, along with answers.

From:
MRC
Published:

Documents

Advanced pain discovery platform: frequently asked questions (PDF)

, 186 KB

If you cannot open or read this document, you can ask for a different format.

Request a different format

Email web@ukri.org, telling us:

  • the name of the document
  • what format you need
  • any assistive technology you use (such as type of screen reader).

Find out about our approach to the accessibility of our website.

Details

The questions and answers covered in detail are:

  • what is the remit of this call in terms of disease conditions, age groups and translational versus basic research?
  • what is the anticipated structure of a consortium and who can participate?
  • what and who can be included in the consortium bid?
  • how will the different phases of the APDP be funded?
  • how will the consortia be evaluated?
  • how are the consortia expected to interact with each other?
  • how can we get involved in consortia applications?
  • how will the recent COVID-19 outbreak affect the consortia call?

Page last updated: 24 January 2022

This is the integrated website of the seven research councils, Research England and Innovate UK.
Let us know if you have feedback or would like to help us test new developments.